Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study Article

Industry Collaboration

cited authors

  • Yardley, Denise A.; Hart, Lowell; Favret, Anne; Blau, Sibel; Diab, Sami; Richards, Donald; Sparano, Joseph; Beck, J. Thad; Richards, Paul; Ward, Patrick; Ramaswamy, Bhuvaneswari; Tsai, Michaela; Blackwell, Kimberly; Pluard, Timothy; Tolaney, Sara M.; Esteva, Francisco J.; Truica, Cristina, I; Alemany, Carlos; Volas-Redd, Gena; Shtivelband, Mikhail; Purkayastha, Das; Dalal, Anand A.; Miller, Michelle; Hortobagyi, Gabriel N.

authors

Publication Date

  • August 1, 2019

webpage

published in

category

keywords

  • Advanced breast cancer
  • CDK4/6 inhibitor
  • First-line
  • HR+/HER2(-)
  • Metastatic
  • Postmenopausal

start page

  • 268

end page

  • +

volume

  • 19

issue

  • 4